| 产品描述: | SCR-1481B1 (Metatinib anhydrous) is a potent compound that has activity against cancers dependent upon Met activation and also has activity against cancers as a VEGFR inhibitor. |
| 靶点: |
VEGFR1 |
| 体外研究: |
More details please refer to Patent WO 2009094417 A1. |
| 参考文献: |
1. Robert M. Borzilleri, et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.218 ml |
6.089 ml |
12.178 ml |
| 5 mM |
0.244 ml |
1.218 ml |
2.436 ml |
| 10 mM |
0.122 ml |
0.609 ml |
1.218 ml |
| 50 mM |
0.024 ml |
0.122 ml |
0.244 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |